Clinical Trial Conference
Bringing therapies quicker to the patient and the patient quicker to research
Date: March 6, 2023
Time: 13h00 – 17h30
Location: Provinciehuis, Provincieplein 1, 3010 Leuven
In line with their previous events on clinical trials, flanders.bio, BioWin and BeCro are very pleased to invite you to their next conference on March 6 in Leuven.
Belgium has a long history of excellent clinical research addressing a wide range of therapeutic domains thanks to a unique health ecosystem, the quality of the clinical centres and the real-life expertise of investigators. Clinical research refers to a multistakeholder landscape in which tracing its path can be a challenging task, in particular for SMEs willing to bring their new health innovations ultimately to the patients.
The increasing importance of data intelligence, the necessary emphasis on patient input, the trend towards more personalised therapeutic approaches all asks for new clinical trial setups and models, from the preparatory phase up to the follow-up.
During the event you will hear the voice of industry (biopharma, biotech and medtech), learn about the hospital’s perspective, and the position of the patient therein. In addition, you will be updated on a number of new trends in the clinical trial landscape.
Mark the afternoon (starting at 13:00) of 6 March in your agenda to attend this interactive day with key players and stakeholders in the Belgian biopharma ecosystem.
13h30 - 16h40 : Welcome
13h40 - 14h00 : The development of a Belgian Clinical Trial Portal: a multi-stakeholder approach, Mitchell Silva (co-founder, Esperity-PatientCentrics)
14h00 - 14h20 : Key success factors to accelerate the translation of research solutions to the patient – what could we do in Belgium to make it possible? Luc Uylenbroeck (Head of Corporate Portfolio Management and Early Solutions Strategy & Operations, UCB)
14h20 - 14h40 : An innovative cancer treatment modality at patient’s home: a recent experience from a biotech company, Frédéric De Coninck (CEO, InhaTarget Therapeutics)
14h40 - 15h00 : Spinovit, a case study of closing the gap between bench and bedside, Nancy Van Overstraeten (CEO, Spinovit)
15h00 - 15h30 : Break
15h30 - 15h50 : Bringing Clinical Trials to Patients home, Ine Vercammen (Study Operations Manager, Delta Healthcare Consulting)
15h50 - 16h10 : Empowering healthcare with real-world evidence, Eveline Dullaers (Healthcare Solution Lead, IQVIA )
16h10 - 16h30 : Patient recruitment approaches with disruptive methods : a Case study where Blockchain would change the Game! Olivier Simon (Visoclinical)
16h30 - 16h50 : Early access program as a pathway to bring innovation to market, Patrick Larcier (Senior Director, Strategic Product Development Solutions, Pharmalex)
16h50 - 17h00 : Q&A
17h00 - 17h25 : Hospital/Academic perspective, Marc Noppen (CEO, UZ Brussel)
17h30 : Networking reception
- Mitchell Silva, co-founder, Esperity-Patient Centric
- Luc Uylenbroeck, Head of Corporate Portfolio Management and Early Solutions Strategy & Operations, UCB)
- Frédéric De Coninck, CEO, InhaTarget Therapeutics
- Nancy Van Overstraeten, CEO, Spinovit
- Ine Vercammen, Study Operations Manager, Delta Healthcare Consulting
- Eveline Dullaers, Healthcare Solution Lead, IQVIA
- Olivier Simon, Visoclinical
- Patrick Larcier, Senior Director, Strategic Product Development Solutions, Pharmalex
- Marc Noppen, CEO, UZ Brussel
Registrations are closed